Structure
ChemicalBook > CAS DataBase List > PNC-27

PNC-27

Structure
Product Name
PNC-27
CAS No.
1159861-00-3
Chemical Name
PNC-27
Synonyms
PNC27
CBNumber
CB24803865
Formula Weight
0
MOL File
Mol file
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

PNC-27 Chemical Properties,Usage,Production

Structure

PNC-27 contains a segment from human p53, residues 12–26, that is involved in the binding of p53 to HDM-2 connected to a membrane penetrating sequence called the membrane residency peptide (MRP). The sequence is H-Pro-Pro-Leu-Ser-Gln-Glu-Thr-Phe-Ser-Asp-Leu-Trp-Lys-Leu-Leu-Lys-Lys-Trp-Lys-Met-Arg-Arg-Asn-Gln-Phe-Trp-Val-Lys-Val-Gln-Arg-Gly-OH[3].

Description

PNC-27 is an anti-cancer peptide that, in small in-vitro studies, has been shown to induce tumour cell necrosis. It is not currently approved for use in the United States (U.S.) and is currently being marketed online as a non-toxic potential cure for various cancers. Recently, the FDA issued warnings to the public regarding PNC-27 use, suggesting possible contamination and unknown side effects of the treatment. PNC-27 may be available in various dosage forms, such as a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. FDA has not evaluated or approved PNC-27 as safe and effective in treating any disease, including cancer[1].

Definition

PNC-27 is an anticancer peptide, containing an HDM-2-binding domain. PNC-27 shows anti-tumor activity and can be used in acute myeloid leukemia research.

in vitro

PNC-27 (50 μg/mL; 0-3 h) induces cancer cell death.
PNC-27 (50 μg/mL; 15 min) binds to cell membrane-bound HDM-2.

in vivo

PNC-27 (intraperitoneal injection; 40 mg/kg; once daily; 2-3 w) shows anti-leukemia activity in vivo.

Mode of action

PNC-27 and its shorter analogue peptide (PNC-28) are peptides that selectively lyse the membranes of cancer cells, resulting in the necrosis of a variety of cancer cell lines and primary human tumours, but not untransformed cells. It is a membrane-active peptide that binds to the HDM-2 protein expressed in the cancer cell membranes of solid tissue tumour cells and induces transmembrane pore formation in cancer, but not in normal cells, resulting in tumour cell necrosis that is independent of p53 activity in these cells. PNC-27 contains residues 12–26 of the HDM-2-binding domain of p53 attached to a leader sequence (termed the membrane residency peptide or MRP) that usually induces the transport of peptides attached to it across the cell and nuclear membranes. The research found that this peptide induced rapid necrosis of cancer cells rather than apoptosis. Induction of tumour cell necrosis was not induced by the isolated p53 12–26 peptide, by the leader sequence alone, or by both separate peptides together, suggesting that both domains must be covalently linked for tumour cell killing[2].

References

[1] Aguon, P. M. et al. “Experimental PNC-27 Therapy and Massive GI Hemorrhage: A Complication or Coincidence?: 1879.” The American Journal of Gastroenterology 7 1 (2017): 0.
[2] Katlin Davitt. “The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.” Annals of clinical and laboratory science 44 3 (2014): 241–8.
[3] Ehsan Sarafraz‐Yazdi. “PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis.” Biomedicines (2022).

PNC-27 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

PNC-27 Suppliers

Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15178
Advantage
58
Chengdu Youngshe Chemical Co., Ltd.
Tel
+86-17380623303 +86-17380623303
Fax
028-62328193
Email
Caroline@youngshechem.com
Country
China
ProdList
4840
Advantage
58
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Fax
0571-87213919
Email
Eric@peptidego.com
Country
China
ProdList
6756
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19553
Advantage
58
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
999
Advantage
58
Nanjing chengqimei Biotechnology Co., Ltd
Tel
19850819832
Email
2173594524@qq.com
Country
China
ProdList
2638
Advantage
58
Wuxi Helen Biotechnology Co., Ltd.,
Tel
0510-85629785 18013409632
Fax
0510-85625359
Email
sales@reading-chemicals.com
Country
China
ProdList
14081
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921 13355716090
Email
Sales@gotopbio.com
Country
China
ProdList
2859
Advantage
58
Molcoo Chemicals Inc.
Tel
18627756402
Email
3001051413@qq.com
Country
China
ProdList
9548
Advantage
58
Nanjing Yuanpeptide Biotech Co.,Ltd.
Tel
18168071971
Email
support@yuan-peptide.com
Country
China
ProdList
2979
Advantage
58
More
Less

View Lastest Price from PNC-27 manufacturers

Cellmano Biotech Limited
Product
PNC-27
Price
US $1.00/g
Min. Order
1g
Purity
98.0% Min HPLC
Supply Ability
2kg
Release date
2019-09-20
Shanghai Affida new material science and technology center
Product
PNC-27 1159861-00-3
Price
US $0.00-0.00/Box
Min. Order
1Box
Purity
99
Supply Ability
10 tons
Release date
2024-03-20
Shanghai Affida new material science and technology center
Product
pnc27 1159861-00-3
Price
US $0.00-0.00/box
Min. Order
1box
Purity
99
Supply Ability
50000KG/month
Release date
2024-06-17

1159861-00-3, PNC-27Related Search:


  • PNC27
  • 1159861-00-3